August 28, 2019

Sponsored by

Webinar Description:
This webinar will provide an overview of liquid biopsy for use in solid tumour cancer treatment selection and monitoring. Topics will include pros and cons of solid and liquid assays for solid tumours, determining the required limit of detection, and send out versus setting up in-house liquid biopsy assays. Dr. Huntsman will also discuss a national early access program to investigate the clinical application of liquid biopsy for therapy stratification and residual disease monitoring.

Learning Objectives:

• Gain an understanding of liquid biopsy applications
• Understand key challenges associated with liquid biopsy assays
• Learn about the real world clinical utility liquid biopsy in lung, breast, and colorectal cancer

Speaker:

Dr. David Huntsman MD, FRCPC, FCCMG
Professor in the Departments of Pathology & Laboratory Medicine and Obstetrics & Gynaecology
University of British Columbia

Dr. Huntsman is the Dr. Chew Wei Memorial Professor of Gynaecologic Oncology, holds the Canada Research Chair (Tier 1) in Molecular and Genomic Pathology, and is a Professor in the Departments of Pathology & Laboratory Medicine and Obstetrics & Gynaecology at The University of British Columbia. He is a Staff Pathologist at BC Cancer and a Consulting Pathologist at the Vancouver General Hospital. Dr. Huntsman is also the co-founder and Director of BC’s Ovarian Cancer Research (OVCARE) Program, where he leads a multidisciplinary team of over 50 scientists, staff and trainees in the study of ovarian and other gynaecological cancers. He is also co-Director of the Genetic Pathology Evaluation Centre (GPEC) at the Jack Bell Research Centre, Vancouver General hospital (VGH) and former Medical Director of the Centre for Translational and Applied Genomics (CTAG) at the British Columbia Cancer Agency (BCCA).

Dr. Huntsman received numerous awards including the prestigious William E. Rawls Prize for contributions to advances in cancer control in Canada (2014), the Gerald Award for Translational Research and Pathology from the Memorial Sloan Kettering Cancer Center (2016), the Karen Campbell National Award for Excellence in Ovarian Cancer Research (Feb 2012), the Killam Research Prize and Overall Excellence Senior Faculty Award from the UBC Faculty of Medicine (2012), and the inaugural Virginia Greene leadership award for ovarian cancer research and advocacy (Sept 2011).

In 2012, Dr. Huntsman started Contextual Genomics together with Dr. Sam Apracio and Dr. Sohrab Shah aiming to provide affordable and reimbursable genetic testing for cancer patients across the globe.

Publications: https://www.ncbi.nlm.nih.gov/pubmed?term=David%20G%20Huntsman